XML 50 R37.htm IDEA: XBRL DOCUMENT v3.20.4
SHAREHOLDERS’ EQUITY (Tables)
12 Months Ended
Dec. 31, 2020
Equity [Abstract]  
reconciliation of the numerators and denominators of the basic and diluted earnings per share

A reconciliation of the numerators and denominators of the basic and diluted earnings per share computations is as follows (dollars and shares in thousands, except per share data):

 

SHAREHOLDERS' EQUITY
       Weighted     
       Average     
       Number of     
   Net   Shares   Per-Share 
For the Year Ended  Income   Outstanding   Amount 
December 31, 2020               
                
Basic earnings per share  $ 7,055    5,871   $1.20 
                
Effect of dilutive stock-based compensation       17      
                
Diluted earnings per share  $ 7,055    5,888   $1.20 
                
December 31, 2019               
                
Basic earnings per share  $ 5,500    5,847   $0.94 
                
Effect of dilutive stock-based compensation       22      
                
Diluted earnings per share  $ 5,500    5,869   $0.94 
                
December 31, 2018               
                
Basic earnings per share  $ 4,900    5,871   $0.83 
                
Effect of dilutive stock-based compensation       38      
                
Diluted earnings per share  $ 4,900    5,909   $0.83 
summary of the outstanding and nonvested stock option activity

A summary of the outstanding and nonvested stock option activity for the year ended December 31, 2020 is as follows:

 

SHAREHOLDERS' EQUITY (Details 2)
   Outstanding   Nonvested 
       Weighted       Weighted 
       Average       Average 
       Exercise       Grant Date 
       Price       Fair Value 
   Shares   Per Share   Shares   Per Share 
Balance, January 1, 2020   29,958   $ 8.79    2,223   $3.24 
                     
Options granted      $        $ 
Options vested      $     (2,223)  $3.24 
Options exercised      $        $ 
Options expired or canceled      $        $ 
                     
Balance, December 31, 2020   29,958   $ 8.79       $ 
summary of options

A summary of options as of December 31, 2020 is as follows (there were no unvested stock options):

 

SHAREHOLDERS' EQUITY (Details 3)
Vested:     
Number of vested stock options   29,958 
Weighted average exercise price per share  $8.79 
Aggregate intrinsic value  $130,617 
Weighted average remaining contractual term in years   3.40 
Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]

 

Restricted Stock
       Weighted 
       Average 
       Grant Date 
Restricted Stock  Shares   Fair Value 
Nonvested at January 1, 2020   43,971   $13.95 
           
Awarded   39,131   $12.45 
Vested   (24,123)  $13.76 
Cancelled   (480)  $13.23 
           
Nonvested at December 31, 2020   58,499   $13.03 
Share-based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]

 

Restricted Stock
Restricted Stock (Continued)            
             
   2020   2019   2018 
   (Dollars in thousands) 
Total intrinsic value of options exercised  $   $60   $137 
Aggregate cash received for option exercises  $   $95   $189 
Total fair value of options vested  $7   $15   $14 
Total compensation cost, options and restricted stock  $425   $338   $227 
Tax benefit recognized  $114   $88   $53 
Net compensation cost, options and restricted stock  $311   $250   $174 
Total compensation cost for nonvested option awards not yet recognized  $   $3   $17 
Weighted average years for compensation cost for nonvested options to be recognized       0.3    1.0 
Total compensation cost for restricted stock not yet recognized  $460   $394   $318 
Weighted average years for compensation cost for restricted stock to be recognized   1.0    0.8    0.8